Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Chocolate Male Supplement Recalled Over Hidden Erectile Dysfunction Drug

MONDAY, March 2, 2026 A chocolate male enhancement product is being pulled from store shelves after federal health officials found it contains a hidden prescrip

New Drug Could Boost Efforts to Wipe Out Sleeping Sickness

MONDAY, March 2, 2026 A new treatment for sleeping sickness could make it much easier to treat and possibly eliminate the deadly disease. On Friday, a committee

FDA To Offer Cash Bonuses for Faster Drug Reviews

MONDAY, March, 2, 2026 The U.S. Food and Drug Administration s (FDA) chief says the agency will begin offering bonuses to drug reviewers who complete their work

Physicians Have Modestly Higher Likelihood of Dying at Home or Hospice

Physicians are modestly more likely to die at home or hospice compared with other highly educated occupational groups, other health care practitioners, and the

CDC Reports on Prevalence of Obesity, Severe Obesity in U.S. Adults, Children

The prevalence of obesity and severe obesity markedly increased among adults and children in the United States from the 1970s and 1980s until now, according to

AAN: GLP-1 Receptor Agonist Initiation for Chronic Migraine Tied to Improved Outcomes

For people with chronic migraine (CM), taking glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with fewer emergency department visits and hos

Cardiovascular Risk Factors, Disease Prevalence Set to Increase Through 2050 in Women

For women and girls, the prevalence of cardiovascular risk factors and disease are projected to increase through 2050, according to a scientific statement publi

Guidance Provided for Transition From Pediatric to Adult Endocrine Care

In a joint guidance document issued by the European Society for Paediatric Endocrinology and European Society of Endocrinology and published online Feb. 25 in t

U.S. Tops 1,100 Measles Cases This Year as Outbreaks Grow

MONDAY, March, 2, 2026 Measles cases are climbing rapidly across the United States, with more than 1,100 infections reported in the first two months of this yea

SystImmune and Bristol Myers Squibb Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan (Iza-bren) in Previously Treated Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer

SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, and Bristol Myers Squibb (NYSE BMY) today announced that SystImmune s parent company, Sic

Popular Keywords